
George L. Maxwell, MD, outlines the SUNFLOWER phase 3 trial assessing Mirena vs oral progestin for treating nonatypical endometrial hyperplasia.

George L. Maxwell, MD, is president of women’s services for the Inova Health System and a gynecologic oncologist.

George L. Maxwell, MD, outlines the SUNFLOWER phase 3 trial assessing Mirena vs oral progestin for treating nonatypical endometrial hyperplasia.